Last reviewed · How we verify

NCT05092126: POPE

Development & Validation of Preoperative Objective Physiological Evaluation

Recruiting now NA Last updated 17 March 2025
What this trial tests

NA trial testing Exercise in Cardiorespiratory Fitness in 100 participants. Currently enrolling.

Timeline
23 November 2021
Primary endpoint
1 March 2026
1 March 2026

Quick facts

Lead sponsorDuke University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designcrossover
Maskingnone
Primary purposediagnostic
Enrollment100
Start date23 November 2021
Primary completion1 March 2026
Estimated completion1 March 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Duke University

Who can join

18 and older, any sex, with Cardiorespiratory Fitness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will compare the measured oxygen consumption (VO2) obtained during sub-maximal exercise testing with the estimated VO2 derived from a non-exercise questionnaire.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Cardiorespiratory Fitness

Currently open trials in the same condition.

Other Duke University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05092126.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing